MedTrace Logo

Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC

NCT04641130 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2020-12-16

No results posted yet for this study

Summary

This is a single center open study designed to determine the concentration of airborne birch pollen inducing an allergic conjunctivitis response in individuals allergic to birch pollen, during allergen exposures in the Alyatec environmental exposure chamber (EEC).

Conditions

  • Allergic Conjunctivitis

Interventions

OTHER

Exposure to birch pollen in EEC

Patients are exposed to airborne birch pollen allergen. The duration of each exposure is 4h maximum.

Sponsors & Collaborators

  • Alyatec

    lead INDUSTRY

Principal Investigators

  • Frédéric de Blay, Pr. · Alyatec

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-13
Primary Completion
2017-08-30
Completion
2017-09-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04641130 on ClinicalTrials.gov